In this Nov. 6, 2019, file photo, Kanye West attends the WSJ. Magazine 2019 Innovator Awards at the Museum of Modern Art in New York. The rap superstar will design adult and kids' clothing that will be sold at Gap in 2021. Yeezy is best known for pricey sneakers that sell out online quickly. But Yeezy footwear, made with sneaker company Adidas, won't be sold at Gap. (Photo by Evan Agostini/Invision/AP, File)
By Joseph Pisani
Kanye West is bringing his Yeezy brand to Gap.
The rap superstar will design adult and kids' clothing that will be sold at the chain's stores next year. Yeezy is best known for pricey sneakers that sell out online quickly. But Yeezy footwear, made with sneaker company Adidas, won't be sold at Gap stores.
San Francisco-based Gap Inc., whose sales are dwindling, hopes the deal will keep it relevant with shoppers. For Yeezy, being in more than 1,100 stores worldwide could get the brand in front of more people.
On Friday, West tweeted a photo of what the collaboration might look like: bright colored hoodies, jackets, and T-shirts.
West has a history with Gap. He worked at one of its stores in Chicago as a teenager. And he told Vanity Fair magazine back in 2015 that he wanted to be creative director of the brand.
As part of the deal announced Friday, Yeezy will receive royalties and possibly Gap stock if the line sells well.
Shares of the retailer jumped 16% in premarket trading.
Adidas said it might have to write off the remaining 300 million euros ($320 million) worth of Yeezy shoes left unsold after it cut ties with rapper Ye, formerly known as Kanye West.
Ivanka Trump began testifying Wednesday in the civil fraud trial that is publicly probing the Trump family business, making an appearance she tried to prevent.
Walmart announced it's looking to create a calm morning shopping experience by turning TV walls to static non-moving images, silencing radios, and dimming store lights.
Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
